PPARD and arthritic joint disease: Notably, expression of PPARδ in mouse MSCs has been shown to impair MSC efficacy in a mouse model of arthritis, while knockdown or antagonism of PPARδ-enhanced mouse MSC efficacy via increased nitric oxide (NO) production [48].